ADVANCED NSCLC
Clinical trials for ADVANCED NSCLC explained in plain language.
Never miss a new study
Get alerted when new ADVANCED NSCLC trials appear
Sign up with your email to follow new studies for ADVANCED NSCLC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could your own tumor cells beat lung cancer? new trial tests it
Disease control Recruiting nowThis study takes white blood cells from a patient's lung tumor, grows them in large numbers in the lab, and gives them back to the patient to fight the cancer. The goal is to see if these specially selected cells can shrink tumors in people with advanced non-small cell lung cance…
Matched conditions: ADVANCED NSCLC
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
New hope for tough lung cancers: dual-antibody combo targets tumors from two angles
Disease control Recruiting nowThis study tests a new drug called JS207, which targets both PD-1 and VEGF, in people with advanced non-small cell lung cancer that got worse after standard chemotherapy and immunotherapy. About 66 participants will receive JS207 alone or combined with another drug (JS004 or doce…
Matched conditions: ADVANCED NSCLC
Phase: PHASE2 • Sponsor: Shanghai Junshi Bioscience Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC